Filing Details

Accession Number:
0001214659-21-000332
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-08 19:14:38
Reporting Period:
2021-01-06
Accepted Time:
2021-01-08 19:14:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576263 Mirati Therapeutics Inc. MRTX Pharmaceutical Preparations (2834) 462693615
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579824 M Charles Baum C/o Mirati Therapeutics Inc.
9393 Town Centre Drive, Ste 200
San Diego CA 92121
President & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-01-06 90 $215.76 91,933 No 4 S Direct
Common Stock Disposition 2021-01-06 4,421 $210.28 87,512 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 3, 2020.